Published • loading... • Updated
uniQure Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into uniQure (QURE)
- SueWallSt notified investors of a pending investigation into potential securities law violations involving uniQure.
- UniQure shares opened 39% lower on September 29, 2026, after 48-month AMT-130 data showed a smaller treatment benefit than data reported at three years.
- AMT-130 reportedly showed a 44% slowing of disease progression at 48 months, compared with 75% at 36 months.
- The investigation will examine whether uniQure made materially false or misleading statements about AMT-130 results and their durability.
Insights by Ground AI
29 Articles
29 Articles
The Logan Banner+27 Reposted by 27 other sources
uniQure Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into uniQure (QURE)
uniQure's four-year AMT-130 Huntington's disease benefit came in smaller than its three-year result, and QURE shares plummeted. SueWallSt notifies investors of a pending investigation into potential securities law violations.
uniQure Sees Unusually High Options Volume (NASDAQ:QURE)
uniQure N.V. (NASDAQ:QURE - Get Free Report) saw some unusual options trading activity on Tuesday. Investors purchased 35,694 call options on the stock. This is an increase of approximately 488% compared to the average volume of 6,074 call options.
·Sioux Falls, United States
Read Full ArticleCoverage Details
Total News Sources29
Leaning Left4Leaning Right2Center20Last UpdatedBias Distribution77% Center
Bias Distribution
- 77% of the sources are Center
77% Center
15%
C 77%
Factuality
To view factuality data please Upgrade to Premium
